Image 4
Image 4
Image
Image
Image 2
Image 2
Image 3
Image 3
Image 5
Image 5
Image 6
Image 6
Image 7
Image 7
Image 8
Image 8
Kaposi sarcoma is driven by KSHV/HHV-8 infection and behaves as a multicentric hyperproliferative process rather than a monoclonal neoplasm, though individual lesions in advanced disease may become monoclonal, suggesting progression to a more neoplastic phenotype.
The hyperattenuating lymphadenopathy (high attenuation relative to muscle) is a highly specific imaging feature for Kaposi sarcoma in the AIDS population, seen in up to 80% of disseminated disease and is key for distinguishing it from other malignancies.
Diagnosis requires tissue biopsy showing spindle cell proliferation, slit-like vascular spaces, and extravasated erythrocytes, confirmed by immunohistochemical staining for HHV-8 LANA; imaging findings alone are not sufficient for diagnosis.
In HIV-AIDS patients, antiretroviral therapy alone can induce regression in many cases with only skin or minimal mucosal involvement, but symptomatic or visceral disease requires ART combined with systemic chemotherapy.
Pulmonary and gastrointestinal tract involvement are major causes of morbidity and mortality, and in 30% of cases visceral disease occurs without concurrent cutaneous involvement, making imaging surveillance essential.
Long-term surveillance is indicated even after treatment response because KSHV persists and recurrence is common; immunosuppressed transplant patients require reduction of immunosuppression as the primary intervention.
Report hyperattenuating lymphadenopathy (high density relative to muscle) in the mediastinum and retroperitoneum, and describe nodules using specific terms such as "bilateral, roughly symmetrical, perilymphatic and peribronchovascular, ill-defined, flame-shaped nodules" with precise location and assessment of surrounding ground glass changes, as these features are highly characteristic of Kaposi sarcoma in the immunocompromised population and aid clinician confidence in diagnosis.